Colorado BioScience Association

Colorado BioScience Association is honored to welcome Terry Fry, M.D., to our Board of Directors.

An internationally recognized pioneer and leader in CAR T-cell therapy, Dr. Fry has helped transform breakthrough science into life-saving treatments that can produce lasting remission, and, for some patients with blood cancers, offer the possibility of a cure.

He brings deep expertise in advancing Colorado’s leadership in cell and gene therapy. His experience will strengthen CBSA’s efforts to connect the state’s innovation ecosystem, elevate Colorado’s reputation as a global hub for health innovation, and accelerate discoveries that improve, extend, and save patients’ lives.

Please join us in welcoming Terry Fry, M.D., to the CBSA Board of Directors!

Read the Announcement: https://cobioscience.com/terry-fry-m-d-joins-colorado-bioscience-association-board-of-directors

Meet our Board of Directors: https://cobioscience.com/meet-cbsa/board-of-directors/

Save the date and reserve your table or ticket now for our ecosystem’s favorite evening of the year!

Colorado BioScience Association’s 23rd Annual Awards Celebration Presented by KBI Biopharma brings together Colorado’s life sciences community for an uplifting evening of impact, inspiration, and connection.

📅 Thursday, November 12, 2026
🕟 4:30 p.m. to 8:30 p.m.
📍 Denver Center for the Performing Arts | Seawell Ballroom

Join hundreds of leaders and innovators as we celebrate the people and organizations advancing health innovation, strengthening our ecosystem, and improving and saving lives.

Bring your team, clients, and partners. This popular event often sells out, so reserve your table or ticket soon.

If you are onsite at the BIO International Convention, don’t miss our dynamic panel discussion, Patients: Our Innovation and Advocacy Partners, tomorrow morning! We are honored to be joined by executives from leading Colorado life sciences companies.

📅 Thursday, June 25, 2026
🕘 9:00 a.m. - 10:00 a.m.
📍 26AB

Learn how our driven innovators integrate the patient voice at all stages of discovery and commercialization and engage with ecosystem partners to build an environment where health innovation thrives.

Moderator: Elyse Blazevich, MS, President & CEO, Colorado BioScience Association

Panelists:
Enveda: Bigyan R. Bista, PhD, Senior Vice President, Capital Formation and Global Partnerships

Edgewise Therapeutics: Abby Bronson, M.B.A., Vice President, Patient Advocacy & External Innovation

Colorado BioScience Association: Amy Berenbaum Goodman, JD, MBE, Vice President and Counsel for Policy + Advocacy

Vināśa Oncology: Sujatha Venkataraman, Ph.D., Founder and Associate Research Professor, University of Colorado Anschutz School of Medicine

Colorado BioScience Association (CBSA) is proud to champion the work of our life sciences community and highlight the global impact of health innovations from our state this week in San Diego.

More: https://lnkd.in/g9gBKCFP

Olympic gold medalist, entrepreneur, cancer survivor, and women's health advocate Shannon Miller will headline the Championing Women's Health Breakfast at the 2026 Rocky Mountain Life Sciences Investor & Partnering Conference Presented by BioMed Realty September 30–October 2, 2026 in Vail, Colorado.

The two-time Olympian earned seven Olympic medals and helped lead the historic "Magnificent Seven" to the first team gold medal in U.S. women's gymnastics history. Today, as Founder & CEO of Salto Health, she helps cancer survivors access products, services, and meaningful support throughout their journeys.

Miller will share her perspective on elite performance and leadership and how her grit, determination, and commitment to learning and reinventing herself supported her cancer journey and inspired her entrepreneurial path.

The conference is also expanding its lineup of investors, strategic partners, and market leaders with:

• Robyn Korkus, Vice President, Enterprise Strategy, Terumo Blood and Cell Technologies

• Chau Khuong, Founder, Chief Investment Officer, CJNV Bioventures

• Dan Lyons, Portfolio Manager, Healthcare and Biotech Teams, Janus Henderson Investors

• Abby Mueller, Investment Associate, Life Sciences Private Capital, J.P. Morgan Private Capital

These leaders join previously announced speakers:

• Alexander Porter, Senior Managing Director, New Listings & Capital Markets, Nasdaq

• Massimo Ruzzene, Senior Vice Chancellor for Research and Innovation and Dean of the Institutes, University of Colorado Boulder

Together, they will explore capital formation, investment trends, strategic partnerships, public markets, quantum innovation, and emerging opportunities across life sciences.

Register now to join founders, investors, strategic partners, and industry leaders from Colorado and the Rocky Mountain West for three days of company presentations, one-on-one partnering, networking, and discussions on the future of health innovation.

Register: https://lnkd.in/gY_qtitk

hashtag hashtag hashtag

Colorado BioScience Association President & CEO Elyse Blazevich was pleased to join leaders from across the region at Bisnow's Denver Metro Life Sciences, Biotech & Quantum Conference. Elyse participated in a fireside chat with Jennifer Chavez, Senior Director of Leasing at BioMed Realty and CBSA Board member, exploring how Colorado's life sciences and quantum ecosystems are driving growth, innovation and long-term investment across the Front Range.

The conversation highlighted the importance of strong partnerships between researchers, entrepreneurs, developers, investors, policymakers and community leaders to create the infrastructure and environment needed for groundbreaking discoveries to thrive.

As Colorado continues to build its position as a leading hub for life sciences innovation, CBSA is proud to champion the collaborations that strengthen our ecosystem and create co-opportunity for organizations of every size and stage.

Thank you to Bisnow, as well as all of the speakers and attendees for an engaging discussion on the future of bioscience growth and innovation in Colorado.

What does world-class intellectual property strategy look like in today's life sciences industry?

Join Colorado BioScience Association and Wilson Sonsini Goodrich & Rosati for an exclusive Thought Leadership Series event, featuring the executives and innovators responsible for protecting and maximizing the value of breakthrough technologies at some of the most influential companies in biotech, genomics, diagnostics, and precision medicine.

Our distinguished panel includes the following intellectual property leaders:

- B.C. Moore, Director, Global Intellectual Property, Illumina

- Rachel Herder, SVP, Legal & Alliance Management (Head of IP), Mammoth Biosciences

- Paul Wickman, SVP, Intellectual Property, Ultragenyx

- Ben Carver, General Counsel, Ambrosia Biosciences Inc.

- Sara P., Partner, Wilson Sonsini

- Bill Barrett, Founder & CEO, TechNomos AI; former Wilson Sonsini partner and former senior IP executive at Illumina and GRAIL

Collectively, these experts have led IP strategy for CRISPR technologies, next-generation sequencing platforms, precision diagnostics, rare disease therapeutics, venture-backed startups, public companies, major acquisitions, licensing transactions, and patent portfolios worth billions of dollars in enterprise value.

If you're a biotech founder, executive, investor, scientist, attorney, or innovation leader, this is a conversation you won't want to miss.

Register Today: https://cobioscience.my.site.com/s/event-details?event=a2HVu00000lTPeI

Congratulations to Founder & CEO, Rose Nash, PhD, and the team at Biota Inc. on the opening of your new 7,500-square-foot laboratory and innovation facility in Longmont.

The new facility will support continued development, validation, and commercialization of Biota’s PFAS monitoring platforms, as well as growth of its scientific and engineering team in Colorado.

"Biota represents the science-driven innovation that defines Colorado's life sciences leadership," said Elyse Blazevich, President and CEO of Colorado BioScience Association. "Their work developing faster and more scalable PFAS monitoring technologies demonstrates how Colorado companies transform breakthrough science into solutions that save and change lives in our state and around the world."

We look forward to your continued success!

Read more: https://www.prnewswire.com/news-releases/colorado-pfas-testing-company-biota-opens-longmont-innovation-facility-amid-growing-demand-for-faster-forever-chemical-monitoring-302789626.html

Colorado PFAS Testing Company Biota Opens Longmont Innovation Facility Amid Growing Demand for Faster "Forever Chemical" Monitoring /PRNewswire/ -- As states, utilities, and environmental teams face growing pressure to monitor and respond to PFAS contamination, Colorado-based environmental...

Member Success: CBSA congratulates three Colorado companies accepted into MedTech Innovator (MTI) 2026 accelerator cohort:

- ForCast Orthopedics, Inc
- GenesisTissue Inc.
- TissueForm, Inc.

Over the next four months, the 65 companies in the cohort will receive world-class mentorship, strategic guidance, and unparalleled access to MTI's ecosystem of investors, health systems, and industry leaders. They'll also compete for a share of over $1.3M in funding.

We look forward to their continued success!

Member Success: Colorado BioScience Association congratulates CBSA member companies Biota Inc., Codebreaker Labs, GenesisTissue Inc., and Intero Biosystems on receiving Advanced Industries Accelerator Grants from the Colorado Office of Economic Development and International Trade.

We also applaud innovators from CBSA’s partner academic and research institutions, including University of Colorado Boulder, University of Colorado Denver, and Colorado School of Mines, who received grant funding to advance promising technologies.

Colorado’s Advanced Industries Accelerator Grant Program continues to deliver powerful results for innovation and economic growth. Since inception, the program has awarded $188.1 million, helped generate $4.3 billion in follow-on capital, and delivered an impressive $22.08 return for every $1 invested.

Strategic state investments strengthen Colorado’s competitiveness by supporting the R&D-intensive industries driving our economy and advancing solutions that save and change lives. Congratulations to all grantees!

Colorado's Advanced Industries Accelerator Program Supports 36 Recipients Developing Cutting-Edge Technologies | Colorado Office of Economic Development and International Trade DENVER - Today, the Global Bus

Last week, CBSA members, staff, and lobbyists met with Colorado Attorney General and gubernatorial candidate Phil Weiser. This valuable touchpoint before the primary election with AG Weiser included discussions about the impact of life sciences across Colorado and allowed CBSA members to share perspectives on key issues affecting innovation, healthcare, workforce, and economic growth in our state.

The meeting was also a critical opportunity for CBSA members to share concerns about the artificial intelligence bill recently passed by Colorado’s General Assembly. AG Weiser indicated that, whether he continues as Attorney General or is elected Colorado’s next governor, he wants to do what he can to make sure some of those concerns are addressed during the upcoming rulemaking process.

Shown in Photo:

Meg Porfido - Phil Weiser for Colorado
Amy Berenbaum Goodman, JD, MBE - Vice President and Counsel, Policy + Advocacy, CBSA
Amy Friedman - Community Engagement Lead, Phil Weiser for Colorado

Row 2:
Elyse Blazevich - President & CEO, CBSA
Rita “Ruta” Sanzgiri, Ph.D. - Intellectual Property Attorney, CBSA Board Secretary and Community Growth & Engagement Committee Chair
Matthew Teter - Vice President of Partnerships, CBSA

Row 3:
Byron Hewett - Life Sciences Executive & Strategic Advisor, CBSA Board Chair
Jenny Nikaido - Community & State Government Relations Sr. Specialist, Terumo Blood and Cell Technologies
Jason Tejani - SVP, Head of Legal, Enveda

Row 4:
Zoey Powers - Senior Director, State Government Affairs, Eli Lilly and Company
Melanie Layton - Co-Owner, Lobbyist, Colorado Legislative Strategies
Robin Harper Cowie - Chief Financial Officer, Biodesix, Inc., CBSA Board Vice Chair

Row 5:
Nate Myszka - Director, State Government Affairs, Medtronic
Caroline Woodhouse - Lobbyist, Colorado Legislative Strategies
Phil Weiser - Colorado Attorney General & Gubernatorial Candidate